Letrozole, an aromatase inhibitor, has been employed to effectively treat endometriosis and relieve endometriosis-associated pain in combination with gestagens, oral contraceptives, or gonadotropin-releasing hormone (GnRH) agonists [25, 47]. The gene discussed is CYP19A1; the disease is endometriosis.